Indication
Hypertension with left ventricular hypertrophy
Hypertension with left ventricular hypertrophy is a manifestation of hypertensive heart disease affecting the cardiovascular system, characterized by persistent systemic blood pressure elevation accompanied by pathological remodeling and an abnormal increase in left ventricular myocardial mass. Read more about Hypertension with left ventricular hypertrophy
72 drugs 51 manufacturers
Drugs that treat it
Common Hypertension with left ventricular hypertrophy therapies.
LOSARTAN POTASSIUM
LOSARTAN POTASSIUM
LOSARTAN (losartan potassium)
LOSARTAN POTASSIUM
LOSARTAN POTASSIUM
LOSARTAN POTASSIUM
LOSARTAN POTASSIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHypertension with left ventricular hypertrophy is a manifestation of hypertensive heart disease affecting the cardiovascular system, characterized by persistent systemic blood pressure elevation accompanied by pathological remodeling and an abnormal increase in left ventricular myocardial mass.
Chronically increased systemic vascular resistance imposes sustained pressure overload on the left ventricle, triggering compensatory cardiomyocyte enlargement, myocardial fibrosis, and chamber wall thickening to reduce wall stress.
Although initially an adaptive response, this remodeling leads to impaired diastolic relaxation, reduced coronary flow reserve, and elevated filling pressures.
Left untreated, it significantly increases the risk of progression to heart failure, cardiac arrhythmias, stroke, and overall cardiovascular mortality.
- nih.gov
Hypertension with left ventricular hypertrophy is a manifestation of hypertensive heart disease affecting the cardiovascular system, characterized by persistent systemic blood pressure elevation accompanied by pathological remodeling and an abnormal increase in left ventricular myocardial mass Chronically increased systemic vascular resistance imposes sustained pressure overload on the left ventricle, triggering compensatory cardiomyocyte enlargement, myocardial fibrosis, and chamber wall thicke...
- nih.gov
Hypertension with left ventricular hypertrophy is a manifestation of hypertensive heart disease affecting the cardiovascular system, characterized by persistent systemic blood pressure elevation accompanied by pathological remodeling and an abnormal increase in left ventricular myocardial mass Left untreated, it significantly increases the risk of progression to heart failure, cardiac arrhythmias, stroke, and overall cardiovascular mortality
- eshonline.org
Chronically increased systemic vascular resistance imposes sustained pressure overload on the left ventricle, triggering compensatory cardiomyocyte enlargement, myocardial fibrosis, and chamber wall thickening to reduce wall stress
- nih.gov
Chronically increased systemic vascular resistance imposes sustained pressure overload on the left ventricle, triggering compensatory cardiomyocyte enlargement, myocardial fibrosis, and chamber wall thickening to reduce wall stress
- nih.gov
Although initially an adaptive response, this remodeling leads to impaired diastolic relaxation, reduced coronary flow reserve, and elevated filling pressures
- nih.gov
Although initially an adaptive response, this remodeling leads to impaired diastolic relaxation, reduced coronary flow reserve, and elevated filling pressures
- nih.gov
Left untreated, it significantly increases the risk of progression to heart failure, cardiac arrhythmias, stroke, and overall cardiovascular mortality
Personalize your experience
Follow Hypertension with left ventricular hypertrophy and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.